Late Effects of Organ Preservation Treatment on Swallowing and Voice; Presentation, Assessment, and Screening by Patterson JM
PERSPECTIVE
published: 21 May 2019
doi: 10.3389/fonc.2019.00401
Frontiers in Oncology | www.frontiersin.org 1 May 2019 | Volume 9 | Article 401
Edited by:
Andreas Dietz,
Leipzig University, Germany
Reviewed by:
Susanne Wiegand,
Leipzig University, Germany
Christiane Hey,
Goethe-Universität Frankfurt,
Germany
*Correspondence:
J. M. Patterson
joanne.patterson@ncl.ac.uk
Specialty section:
This article was submitted to
Head and Neck Cancer,
a section of the journal
Frontiers in Oncology
Received: 30 January 2019
Accepted: 29 April 2019
Published: 21 May 2019
Citation:
Patterson JM (2019) Late Effects of
Organ Preservation Treatment on
Swallowing and Voice; Presentation,
Assessment, and Screening.
Front. Oncol. 9:401.
doi: 10.3389/fonc.2019.00401
Late Effects of Organ Preservation
Treatment on Swallowing and Voice;
Presentation, Assessment, and
Screening
J. M. Patterson 1,2*
1 Institute for Health and Society, Newcastle University, Newcastle upon Tyne, United Kingdom, 2 Speech and Language
Therapy Department, City Hospitals Sunderland Foundation Trust, Sunderland, United Kingdom
The prevalence of head and neck cancer (HNC) survivors is on the rise. Treatments
for HNC can have a major deleterious impact on functions such as swallowing and
voice. Poor functional outcomes are strongly correlated with distress, low quality of
life, difficulties returning to work and socializing. Furthermore, dysphagia can have
serious medical consequences such as malnutrition, dehydration, and pneumonia.
A conservative estimate of the percentage of survivors living with dysphagia in the
long-term is between 50 and 60%. Evidence is emerging that functions can worsen
over time, sometimes several years following treatment due to radiation-associated
fibrosis, neuropathy, intractable edema, and atrophy. Muscles lose their strength,
pliability, stamina, and range, speed, precision, and initiation of movements necessary
for swallowing and voice functions. Late treatment effects can go unrecognized, and
may only be identified when there is a medical complication such as hospitalization for
aspiration pneumonia. In the routine healthcare setting methods of evaluation include
a detailed case history, a thorough clinical examination and instrumental assessments.
Interventions for late treatment effects are limited and it is imperative that patients at
risk are identified as early as possible. This paper considers the role of screening tests in
monitoring swallowing and detecting aspiration in the long-term. Further work is indicated
for addressing this pressing and increasingly common clinical problem.
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INTRODUCTION
The prevalence of head and neck cancer (HNC) survivors is on the increase, likely due
to improvements in diagnostic technologies, treatment techniques, and a rising number of
HPV-related oropharyngeal cancers, with patients presenting at a younger age with good survival
outcome (1). HNC treatments can result in a multitude of side effects resulting in poor
function. Post-treatment swallowing and voice difficulties are strongly related to psychosocial
problems, poorer quality of life, anxiety, and low mood (2, 3). In addition, dysphagia can pose a
serious medical threat, being associated with malnutrition, dehydration, and possibly pneumonia.
Survivors may therefore live for a long time with significant symptom burden, which can increase
in severity over time. This paper reports on the presentation, assessment, and potential screening
tests for late treatment effects on swallowing and voice.
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THE COMPLEXITY OF SWALLOWING AND
VOICE
Swallowing and voice are highly coordinated, specialized
functions involving over 25 pairs of muscles under both
voluntary and involuntary control. Swallowing is a finely tuned
process, primarily because the oropharynx is a shared passageway
for swallowing and respiration. It needs to be executed safely,
avoiding spillage into the airway, and efficiently, to ensure
adequate nourishment and hydration. Voice is produced by air
passing through the vocal folds, causing the edges to vibrate
rapidly. This sound is amplified by resonating cavities in the
vocal tract, giving it a distinctive quality. The active articulators
(tongue, lips and soft palate) modify the voiced sound into speech
via quick and precise movements.
LATE TREATMENT EFFECTS ON
FUNCTION
Surgical treatment for HNCmay result in functional impairment,
dependent on factors such as tumor site, volume resected,
reconstruction, and the subsequent level of edema, scarring,
and atrophy (4). Radiotherapy can create significant dysfunction
both acutely and progressively also termed “late effects.” Acute
radiotherapy side effects usually include pain, mucosititis, edema,
and xerostomia. For some, this results in mild or short-term
dysphagia and dysphonia, resolving by 3 months. This group are
likely to return to their normal diet with minor limitations. This
is a typical pattern for those treated by low dose radiotherapy
(2, 5), but may be achieved by a small percentage of patients with
advanced disease treated by intensity-modulated radiotherapy
(IMRT) (6).
DYSPHAGIA
Evidence relating to the long-term impact of treatment
on swallowing is emerging, with a number of potential
patterns described by Christianen (5). Some patients experience
progressive deterioration in the months and years following
treatment, whereas others may have a sudden onset of severe
dysphagia. Causes of these differing trajectories are not well-
understood. Chronic edema and increased fibroblast formation
are responsible for the overproduction of collagen, leading
to scarring, and fibrosis (7). Consequently, tissues lose their
elasticity and movements for adequate functioning are restricted.
Atrophy can alter oropharyngeal anatomical relationships and
reduce muscle strength. Furthermore, sensory impairment can
blunt the cough response, should food, or drink enter the airway.
Lower cranial nerve palsies (CN IX, X, and XII) have been
noted, probably due to compression or direct nerve damage
(8). Mandible osteoradionecrosis is a further late complication,
resulting in exposed, non-healing bone (9). This is strongly
associated with severe, chronic dysphagia (OR: 4.6, 95% CI:
2.1–10.3), making chewing painful and swallowing less efficient
(10). Dysphagia is strongly associated with psychological distress,
poorer quality of life, and is a top priority concern for HNC
survivors (2, 11, 12)
Prevalence of Late Effects Dysphagia
Little information is published on swallowing outcomes beyond
2 years. In our longitudinal study (n = 146 recruited pre-
treatment), aspiration rates remained stable between one and 6
years following chemoradiotherapy (22–25%), with one half of
these patients having silent aspiration (13). At 1 year, two patients
had a laryngectomy for a dysfunctional larynx and four had a
tracheostomy due to airway compromise. By 6 years, five further
patients had a laryngectomy for a dysfunctional larynx (13). An
Australian study reported a decline in swallowing efficiency over
the same time frame (14). The RTOG 91–11 5 year follow up
identified severe dysphagia in a third of the retained sample (15).
SEER data reported a 49% rate of persistent dysphagia (16, 17),
with older patients following non-surgical treatment being most
at risk (18, 19).
Dysphagia Associated Risk
Aspiration is a medical concern as it can lead to repeated
chest infections, poor pulmonary function, and life-threatening
aspiration pneumonia (20). In our 6 year follow up cohort, 28%
reported at least one chest infection, with an increased risk ratio
of 6.25 [p = 0.03 CI 1.1–35.7] for aspirators (13). Seven percent
of those initially diagnosed with oropharyngeal cancer had a non-
functioning larynx, requiring complex, and major reconstructive
surgery (13). SEER data suggests the incidence of aspiration
pneumonia in HNC is 8.7% (95% CI: 8.2–9.1) (17) and it is
estimated that over 80% require hospital admission, half of whom
transfer to intensive care (20). Case series and cross-sectional
data report alarmingly high rates of aspiration-related deaths
(21–23). For example, the 30-day mortality rate in a series of
nasopharyngeal cancer patients was 51% (24). It is crucial that
we identify those at risk of developing aspiration pneumonia as
early as possible.
DYSPHONIA
The prevalence of late voice problems are not well-documented.
Small studies suggest deterioration in patient reports and clinical
tests of voice up to 7 years post-treatment (25, 26). However,
patients treated with IMRT appear to have better outcomes than
those treated with conventional radiotherapy, in the long-term
(3). A small percentage of patients may require a tracheostomy
or laryngectomy, significantly altering voice quality (13).
ASSESSMENT
Clinical Swallowing and Voice Assessment
In the first instance, patients presenting with new symptoms,
or deterioration in function should have recurrent or primary
disease excluded as a possible cause. A comprehensive clinical
history of late effects will include details on patients’ perceptions
of the onset, trajectory, and symptoms. Clinical information
such as co-morbidities, reflux, chest status, oral intake, oral
hygiene, and weight should be gathered. For older survivors,
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expected, age-related functional decline i.e., loss of muscle mass
and elasticity, reduced saliva production should be taken into
account. An examination will typically include and oral and
oromotor assessment, palpation of laryngeal structures, voice,
and speech quality assessment and an observation of eating
and drinking.
There are no agreed standards for long-term voice assessment,
although review papers call for structured, standardized
protocols, with measurements taken at baseline and long-
term (27, 28). These typically include clinician rated scales,
intelligibility rating, and acoustic measures (29). Examples of
scales and measures used in HNC are given in Table 1.
Patient Reported Outcome Measures
Measures of function in HNC should include patient-
reported outcomes both pre- and post-treatment. Swallowing
questionnaires and symptom report tools capture patients’
perspectives of dysphagia, but they are only weakly correlated
with swallowing impairment and aspiration, the relationship
being particularly poor beyond 12 months post-treatment.
They are therefore not interchangeable with clinical
assessment (36, 37). The most commonly reported swallowing
questionnaires used in HNC care include M.D. Anderson
Dysphagia Inventory (38), SWAL-QOL (39), Sydney Swallow
Questionnaire (40), and the EAT-10 (41). Examples of patient
reported voice questionnaires include Voice Handicap Index
(30), Voice Symptom Scale (32), and the Vocal Performance
Questionnaire (42).
Instrumental Assessment
Instrumental examination(s) is indicated for a thorough
investigation of pathophysiology. Videofluoroscopy (VF) and
TABLE 1 | Examples of voice outcome measures used in HNC.
Voice measures Description
Patient reported measures Voice handicap index VHI-10 (30). 10 items on 5
point scale
Voice-related quality of life V-RQOL (31). 10 items, 5
point scale and an overall score
Voice symptom scale VoiSS (32). 30 items 3
subscales impairment-related, emotional, and
physical symptoms
Vocal performance questionnaire VPQ (33). 12
items, 5 point ordinal scale
Clinician rated measures GRBAS (34) roughness, breathiness, asthenia,
strain. 4 point scale for each area and overall grade
Consensus Auditory-Perceptual Evaluation of Voice
(CAPE V) (35). Overall severity, roughness,
breathiness, strain, pitch, loudness. 6 vocal
attributes measured on a visual analog scale
Acoustic and aerodynamic
measures
Fundamental frequency-vocal fold vibration
frequency
Pertubation-Jitter: irregularities in vocal fold
frequency, Shimmer: amplitude irregularities.
Harmonic to noise ratio-ratio of sound frequencies
to noise energy in the voice
Maximum phonation time-glottic efficiency
Fiberoptic Endoscopic Evaluation of Swallowing (FEES R©) are the
most commonly used instrumental swallow assessments (43). VF
is a recorded radiographic study of the swallowing structures,
their movement and co-ordination. It is usually conducted in the
lateral and anterior-posterior plane. Test boluses are mixed with
radio-opaque material to enable visualization. FEES R© allows a
direct view of nasolaryngopharyngeal anatomy and physiology
followed by an assessment of swallowing function (44, 45). A
range of fluid and food can be given, without requiring radio
opaque contrast. This may be combined with a voice assessment,
which also requires a stroboscopic light source to fully assess
vocal fold function and mucosal wave pattern.
The presentation of late treatment effects on instrumental
assessment constitutes a number of features such as;
• Excessive external lymphedema, with underlying
tissue hardening.
• Internal edema in critical structures and spaces for functioning
e.g., true vocal folds, epiglottis, pyriform sinuses.
• Thickening of structures e.g., pharyngo-epiglottic folds
creating a shelf-like barrier to bolus flow.
• Muscle thinning e.g., atrophied tongue base and
pharyngeal wall.
• Palsies of the tongue, vocal fold, soft palate.
• Excessively dry laryngopharyngeal muscosa.
The pathophysiology, safety, and efficiency of swallowing can be
analyzed and measured using rating scales, a selection of which
are presented in Table 2.
MONITORING
Cancer surveillance reviews are usually offered up to 5 years
following treatment (1). Swallowing and voice function may
TABLE 2 | Examples of swallowing rating scales for FEES® and VF.
Rating scale Assessment
FEES VF
Penetration Aspiration Scale (49)
8-point scale describing laryngeal penetration and
aspiration and sensory response
Yes Yes
The MBS Impairment Scale (50)
16-item scale of swallow physiology and residue
No Yes
Dynamic Image Grade of Swallowing Toxicity
(DIGEST) (51)
Summary score for swallow safety and efficiency
No Yes
Oropharyngeal swallow efficiency (52)
Combined measure of residue and aspiration
No Yes
Patterson’s Oedema Scale (53)
4-point scale of laryngopharyngeal structures and
spaces
Yes No
The Boston Residue and Clearance Scale (54)
11-point scale scoring amount, location and
clearance of residue
Yes No
Yale Pharyngeal Residue Severity Rating Scale (55),
5-point scale on amount of pharyngeal residue
Yes No
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not be routinely tested, unless patients report a problem. One
preliminary study proposes four questions that could be used
as part of a clinical assessment to detect dysphagia i.e., Do you
have difficulties: (1) drinking? (2) eating? (3) swallowing? (4)
Do you cough when eating/drinking? When three or more of
these questions were answered affirmatory, the likelihood of
aspiration observed on VF increased (46). Given afore described
mortality risks, and the preponderance of sub-clinical aspiration,
the immediate clinical challenge is identifying those at risk
of developing pneumonia, using reliable, repeatable, and cost-
effective tests.
Identifying Patients at Risk of Aspiration
Pneumonia
Healthy adults can experience trace aspiration without
adverse consequences, and not every HNC survivor with
aspiration appears to develop pneumonia. In a series of partial
laryngectomy patients, 65% were identified with aspiration,
but without x-ray evidence of pneumonia or infection (47).
There may be additional factors to be taken into account,
when weighing up pneumonia risk. For example, older
adults in a care facility developed pneumonia only when
aspiration co-occurred with poor oral hygiene, dependence
on others for eating, poor dentition and co-morbidities
(48). Most HNC studies have explored patient and disease
characteristics and treatment type as predictors of pneumonia,
with no clear pattern emerging (see Table 3). Further work
on identifying predictor variables for aspiration pneumonia
to be used as part of an algorithm for monitoring purposes
is required.
Screening Assessments
Instrumental assessments provide a more objective way of
measuring swallowing, but have limited access and high cost,
due to the need for specialist equipment and personnel (56). In
Stroke care, early detection of dysphagia by screening reduces
pulmonary complications, length of hospital stay, and overall
health care costs (57). No such programme exists for HNC
survivors, but the following section reviews candidate screening
tests for this group.
Water Swallow Test
A water swallow test (WST) is the most commonly reported
aspiration screening tool (58). Two systematic reviews report
a range of protocols, predominantly for testing neurological
dysphagia (56, 58–61). Using prescribed amounts of water and
recording coughing or a wet voice gave the most accurate
results for identifying aspiration (56, 62). Consecutive sips
with large volumes had the best sensitivity (91% CI 89,
93%) while, single sips of water were better at ruling out
aspiration (90% CI 86, 93%) (58). We have reported on
the timed 100 mLs WST in HNC, recording swallowing
performance overtime, as well as a screening test for aspiration
(63). This test was acceptable for identifying aspiration in
early post-operative or chemoradiotherapy patient groups
(63, 64), but its reliability for late effects patients has not
been investigated.
Cough Reflex Test
This test assesses the cough reflex by introducing a tussive agent
such as citric acid via a facemask and nebulizer and observing
for a responsive cough (65). The outcome is judged on reflexive
cough strength and has been used as screening test in Stroke (65),
Parkinson’s Disease (66), and post-extubation (67). The absence
of a cough reflex in neurological patients has a sensitivity of 69%
(95% CI 55, 81%) and specificity of 71% (95% CI 63, 77%) to
detect aspiration (65). No studies have reported on its use in
HNC, but given that late effects can result in silent aspiration,
further investigation is warranted.
Pulmonary Function
Many patients elect to eat and drink despite experiencing
aspiration. Assessments to monitor pulmonary function
such as spirometry and flow-volume loops may be
TABLE 3 | HNC studies reporting predictors of (1) aspiration pneumonia* (2) aspiration pneumonia-related death** 6= Wang et al. (24) only included patients with a
diagnosis of aspiration pneumonia.
Author N T site Tx % AP Predictors of AP Non-predictive
Hunter et al. (69) 72 OPSCC C-IMRT 22% T-stage, patient report, aspiration on
VF*
CTCAE
Xu et al. (20) 3513 Mixed Surgery and RT, CRT, RT 16% 1Y 24% 5Y Hypopharynx or NPC, gender, age,
co-morbidity, primary RT, care at
non-teaching hospital*
Surgery, stage, type of CT, type
of RT
Kawai et al. (70) 305 Mixed CRT 21% Alcohol, sleeping pills, oral hygiene,
hypoalbumemia, presence of other
cancer*
Madan et al. (71) 85 Mixed Surgery & RT, CRT, RT 60% Pharynx cancer, T stage** Age, gender, tx modality,
smoking, co-morbidity, treatment
intent, baseline swallowing
Wang et al. (24) 113 NPC RT +/– CT IMRT 100% 6= age, smoking, weight loss, lower CN
palsy**
O’Hare et al. (72) 206 Mixed RT +/– CT 15% Larynx cancer, dose to cricopharynx** Gender, chemotherapy
NPC, nasopharynx cancer; OPSCC, oropharynx cancer; T, tumor; Tx, treatment; CRT, chemoradiotherapy; RT, radiotherapy; CT, chemotherapy.
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indicated together with close collaboration with Respiratory
Physicians to develop mechanisms to detect deterioration in
chest status.
FUTURE DIRECTIONS
There are a number of current trials investigating treatment
modulation to prevent or reduce toxicities without
compromising survival (68). In the meantime, further work on
late functional effects is indicated in the following areas.
• Information on the long-term outcomes for voice and speech.
• Identification of predictors of significant fibrosis and
exploration of preventative interventions.
• Identification of predictor variables for pneumonia in patients
who aspirate.
• Reliable screening tests for identifying aspiration and
dysphagia for long-term follow up.
• Accurate patient information regarding late treatment effects.
• Clinical care pathways for identifying and monitoring late
functional effects.
CONCLUSION
The number of HNC survivors is rising and this trend
is set to continue. Late functional effects of treatment is
a common, distressing, and potentially life-threatening
problem. Assessment and monitoring of HNC survivors
in the long-term is an important step for identifying
those at risk, as early as possible. Reliable, acceptable, and
repeatable screening assessments are needed to address this
growing problem.
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